JcvasqV Profile Banner
Juan Vasquez, MD Profile
Juan Vasquez, MD

@JcvasqV

Followers
432
Following
1K
Media
33
Statuses
288

pedi oncologist @Yalemed @yalecancer @yalepediatrics, studying interface of DNA repair, metabolism and immunology in cancer. Opinions are not medical advice

Joined December 2012
Don't wanna be here? Send us removal request.
@JcvasqV
Juan Vasquez, MD
2 months
Awesome work by my fantastic mentor and collaborator @ranjitbindra ✋🏽🤚🏽!!.
@YaleCancer
Yale Cancer Center
2 months
The #BindraLab focuses on developing novel .anti-cancer therapeutics for a wide range of solid tumors. Watch as @ranjitbindra describes their research on #DNArepair, #cancermetabolism, and #noveltherapeutics. .@SmilowCancer @YaleMed @YNHH.
0
1
2
@JcvasqV
Juan Vasquez, MD
2 months
@AngKim99
Angela Kim
2 months
Had an amazing time at @YaleCancer 8th annual symposium! I had the honor of presenting our work on NAPRT-loss in pediatric rhabdomyosarcoma. All thanks to my amazing mentors, @JcvasqV and @ranjitbindra, as well as all the collaborators 🙌. @Shahyan_Rehman @yalepathology
Tweet media one
1
2
7
@grok
Grok
5 days
Join millions who have switched to Grok.
202
406
3K
@JcvasqV
Juan Vasquez, MD
4 months
@Shahyan_Rehman
Shahyan Ur Rehman, MD
4 months
Huge shoutout to the Vasquez Lab for a team effort 🔬 @JcvasqV @AngKim99 @YalePediatrics.
0
1
3
@JcvasqV
Juan Vasquez, MD
4 months
Looking for a high-throughput and automated approach to analyze nuclei-based growth delay assays? Great work by James Elia from the Bindra lab! @ranjitbindra @yalepathology @YaleCancer @AACR
Tweet media one
0
2
7
@JcvasqV
Juan Vasquez, MD
4 months
Wonderful talk by @AngKim99 on loss of NAPRT expression in rhabdomyosarcoma and implications for therapeutic targeting of NAD! @YalePediatrics @YaleCancer @yalepathology @ranjitbindra
Tweet media one
Tweet media two
0
3
6
@JcvasqV
Juan Vasquez, MD
4 months
Amazing poster on targeted CRISPR screen to discover chemo-genomic interactions by @HeerCollin from the Bindra Lab!! @YaleCancer @ranjitbindra
Tweet media one
0
1
6
@JcvasqV
Juan Vasquez, MD
4 months
Thank you to OncLive for highlighting our work on targeting NAD metabolism in rhabdomyosarcoma! @OncLive @YalePediatrics @YaleCancer.
@OncLive
OncLive.com
4 months
Thank you to @JcvasqV, of @YaleCancer, for stopping by at #AACR25 to discuss NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma! Check out our site for more from the meeting. @AACR.#pediatriccancer #oncology
Tweet media one
0
3
5
@JcvasqV
Juan Vasquez, MD
4 months
Great work by a very talented surgeon-scientist that has been crushing it in the lab! @YaleCancer @YalePediatrics @YaleSurgery.
@APSASurgeons
APSA Surgeons
4 months
#APSA25 will be here soon! Join us for an inspiring session on Therapeutic Use of NAMPT Inhibitors in Neuroblastoma where Dr. Shahyan Rehman will share groundbreaking insights and practical takeaways shaping the future of pediatric surgery. #PediatricSurgery #APSAsurgeons
Tweet media one
1
2
8
@JcvasqV
Juan Vasquez, MD
4 months
Interested in how we're targeting NAD metabolism in rhabdomyosarcoma? Don’t miss what’s sure to be an amazing oral presentation by @AngKim99 at AACR on 4/29! @YaleCancer @YalePediatrics @ranjitbindra @aacr.
@YalePediatrics
Yale Pediatrics
4 months
Yale Cancer Center Research Breakthroughs Unveiled at AACR Annual Meeting @JcvasqV.
1
2
8
@JcvasqV
Juan Vasquez, MD
5 months
Happy to contribute to this important piece on the wide spectrum of presenting signs and symptoms of neuroblastoma, including opsoclonus-myoclonus, a rare paraneoplastic syndrome ⁦@YalePediatrics⁩ ⁦@YaleCancer
Tweet card summary image
newsweek.com
Christie Seibold shared the video in the hope that "more babies be diagnosed as soon as possible."
0
2
3
@JcvasqV
Juan Vasquez, MD
5 months
RT @YalePediatrics: Dr. Juan Vasquez at @YaleMed: "Neuroblastoma can present with a variety of symptoms, and early signs may be subtle. One….
Tweet card summary image
newsweek.com
Christie Seibold shared the video in the hope that "more babies be diagnosed as soon as possible."
0
1
0
@JcvasqV
Juan Vasquez, MD
5 months
Big congratulations to @angkim99 for passing quals!!!🎉🎉 Fabulous PhD candidate co-mentored with @ranjitbindra. Excited to see all the great science ahead! @YalePediatrics @YaleCancer @yalepathology @yalegsas @YaleMed
Tweet media one
1
2
10
@JcvasqV
Juan Vasquez, MD
1 year
RT @ranjitbindra: Shout out to former Bindra Lab grad students, 1st author @KatelynNoronha (thesis project)+fellow former grad student coll….
0
1
0
@JcvasqV
Juan Vasquez, MD
1 year
A little late, but happy to share our review on targeting DNA repair pathways in pediatric solid tumors and implications for immunotherapy! #mdpicancers via @Cancers_MDPI @YaleCancer @YalePediatrics.
1
2
5
@JcvasqV
Juan Vasquez, MD
1 year
Amazing introductory talk by NCI director Dr. Rathmell at the Professional Development Workshop! @theNCI @NCICRCHD @YaleCancer @YalePediatrics
Tweet media one
0
1
2
@JcvasqV
Juan Vasquez, MD
1 year
A little late, but excited to share our review on targeting DNA repair pathways in pediatric tumors! .#mdpicancers via @Cancers_MDPI @YaleCancer @YalePediatrics.
0
0
1
@JcvasqV
Juan Vasquez, MD
1 year
RT @YaleCancer: New research from the labs of @ranjitbindra and @JcvasqV showed the impact and therapeutic vulnerabilities of nicotinamide….
0
5
0
@JcvasqV
Juan Vasquez, MD
1 year
RT @ranjitbindra: Even better than Bindra Lab dinner? Joint lab dinner, with the labs of two former Bindra Lab trainees!.@SusanGueble @Jcva….
0
3
0
@JcvasqV
Juan Vasquez, MD
2 years
Excited to share our study on characteristics and outcomes of children with RMS and isolated pulmonary mets! Thank you @CarolaArndtMD, @drrajkumar and all co-authors! And thanks to @COGorg STS committee! @YalePediatrics @YaleCancer @WileyOnc_Hem .
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
With aggressive treatment, patients with ERMS and lung-only metastatic disease have superior EFS and OS compared with patients with other sites of metastatic disease, even when older than 10 years of...
0
3
8